Asarina Pharma expects to release top-line results of its Phase IIb PMDD study on schedule at the end of April. Asarina Pharma’s other studies on… Read More »Asarina Pharma to release historic Phase IIb PMDD data on schedule
Asarina Pharma’s March 26 R&D day will now be streamed live via digital link due to Coronavirus restrictions. The event focuses on preparing for the… Read More »Asarina Pharma R&D Day 2020 to go digital
Asarina Pharmas R&D dag torsdagen den 26 mars kommer att vara helt digital på grund av det nya coronaviruset. Fokus kommer att ligga på kommande… Read More »Asarina Pharmas R&D-dag 2020 nu digital
Asarina Pharma bjuder in institutionella investerare, finansanalytiker och media till en R&D-dag med fokus på kommande studieresultat i bolagets ledande indikation PMDS. Datum: 26 mars… Read More »Inbjudan till Asarina Pharmas R&D-dag 2020
Asarina Pharma invites institutional investors, financial analysts and media to join its R&D day, focused on the upcoming Study results in the company's lead indication… Read More »Invitation to Asarina Pharma R&D Day 2020
(Stockholm, 20 February, 2020) Asarina Pharma AB (publ) (“Asarina Pharma” or the “Company”) today announces that it will, pursuant to the authorisation granted by the… Read More »Asarina Pharma issues new shares to Ergomed plc
(Stockholm, 20 februari, 2020) Styrelsen i Asarina Pharma AB (publ) (“Asarina Pharma” eller ”Bolaget”) har, med stöd av bemyndigande från Bolagets extra bolagsstämma den 21… Read More »Asarina Pharma emitterar 301 724 aktier till Ergomed plc
Asarina Pharma AB (publ) höll idag, den 21 januari 2020, extra bolagsstämma i Stockholm. Bolagsstämman valde styrelsens ordförande Paul de Potocki till stämmoordförande och advokat… Read More »Asarina Pharmas extra bolagsstämma
Today, on 21 January 2020, Asarina Pharma AB (publ) held an extraordinary general meeting (“EGM”) in Stockholm, Sweden. The EGM elected the chairman of the… Read More »Asarina Pharma’s extraordinary general meeting
The shareholders of Asarina Pharma AB (publ) are hereby summoned to attend the Extraordinary General Meeting (“EGM”) on 21 January 2020, at 10.00 at Erik… Read More »NOTICE OF EXTRAORDINARY GENERAL MEETING IN ASARINA PHARMA AB (PUBL)